Anavex Life Sciences Corp (NASDAQ:AVXL)
| 9.09 Delayed Data As of Jun 01 |  -0.14 / -1.52%Today’s Change | 7.36 Today|||52-Week Range 15.24 | -1.84% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 995.00 | 1.3K | 0.00 | 0.00 | ||
| Operating Expenses | Gross Income | -995.00 | -1.3K | 0.00 | 0.00 | |
| General Expenses | 7.1M | 15.6M | 15.7M | 19.3M | ||
| Research And Development | 2.3M | 7.3M | 10.7M | 13.3M | ||
| Total Operating Expenses | 7.1M | 15.6M | 15.7M | 19.3M | ||
| Non-Operating Expenses | Operating Income | -7.1M | -15.6M | -15.7M | -19.3M | |
| Extraordinary Credit | 84.8K | 212.6K | 75.2K | 0.00 | ||
| Interest Expense On Debt | 5.2M | 0.00 | 0.00 | 0.00 | ||
| Other Expenses | 70.6K | -48.4K | -47.6K | -80.7K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.1M | -14.7M | -15.4M | -19.0M | |
| Income Taxes | 0.00 | -29.6K | -2.0M | -1.6M | ||
| Net Income | -12.1M | -14.7M | -13.5M | -17.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 18.6M | 35.2M | 40.8M | 44.7M | |
| Shares To Calculate EPS Diluted | 18.6M | 35.2M | 40.8M | 44.7M | ||
| Earnings Per Share | EPS | -$2.60 | -$0.42 | -$0.33 | -$0.39 | |
| EPS Diluted | -$0.65 | -$0.42 | -$0.33 | -$0.39 | ||
